Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

2.

Direct nitrate reductase assay versus microscopic observation drug susceptibility test for rapid detection of MDR-TB in Uganda.

Bwanga F, Haile M, Joloba ML, Ochom E, Hoffner S.

PLoS One. 2011 May 9;6(5):e19565. doi: 10.1371/journal.pone.0019565.

3.

Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.

Dang TM, Nguyen TN, Wolbers M, Vo SK, Hoang TT, Nguyen HD, To MH, Vuong MB, Nguyen TP, Tran VQ, Nguyen TB, Vo TH, Nguyen TN, Dai VH, Phan TH, Nguyen HD, Farrar J, Caws M.

BMC Infect Dis. 2012 Mar 1;12:49. doi: 10.1186/1471-2334-12-49.

4.

Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.

Shah NS, Moodley P, Babaria P, Moodley S, Ramtahal M, Richardson J, Heysell S, Li X, Moll A, Friedland G, Sturm AW, Gandhi NR.

Am J Respir Crit Care Med. 2011 May 15;183(10):1427-33. doi: 10.1164/rccm.201009-1449OC. Epub 2011 Feb 4.

PMID:
21297071
5.

Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.

Huang Z, Qin C, Du J, Luo Q, Wang Y, Zhang W, Zhang X, Xiong G, Chen J, Xu X, Li W, Li J.

J Antimicrob Chemother. 2015 Feb;70(2):456-62. doi: 10.1093/jac/dku384. Epub 2014 Sep 28.

PMID:
25266071
6.

Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis.

Minion J, Leung E, Menzies D, Pai M.

Lancet Infect Dis. 2010 Oct;10(10):688-98. doi: 10.1016/S1473-3099(10)70165-1. Epub 2010 Aug 31. Review.

PMID:
20813587
7.

Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis.

Bwanga F, Hoffner S, Haile M, Joloba ML.

BMC Infect Dis. 2009 May 20;9:67. doi: 10.1186/1471-2334-9-67. Review.

8.

Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.

Coronel J, Roper MH, Herrera C, Bonilla C, Jave O, Gianella C, Sabogal I, Huancaré V, Leo E, Tyas A, Mendoza-Ticona A, Caviedes L, Moore DA.

Clin Microbiol Infect. 2014 Jun;20(6):536-41. doi: 10.1111/1469-0691.12401. Epub 2013 Nov 21.

9.

Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.

Makamure B, Mhaka J, Makumbirofa S, Mutetwa R, Mupfumi L, Mason P, Metcalfe JZ.

PLoS One. 2013;8(2):e55872. doi: 10.1371/journal.pone.0055872. Epub 2013 Feb 11.

10.

Evaluation of the Xpert® MTB/Rif test, microscopic observation drug susceptibility test and nitrate reductase assay, for rapid and accurate diagnosis of smear-negative tuberculosis in HIV patients.

Walusimbi S, Bwanga F, Costa AD, Haile M, Hoffner S, Joloba M.

Int J Mycobacteriol. 2013 Sep;2(3):148-55. doi: 10.1016/j.ijmyco.2013.06.001. Epub 2013 Jul 12.

11.

The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.

Martin A, Panaiotov S, Portaels F, Hoffner S, Palomino JC, Angeby K.

J Antimicrob Chemother. 2008 Jul;62(1):56-64. doi: 10.1093/jac/dkn139. Epub 2008 Apr 10. Review.

PMID:
18407918
12.
13.
14.

Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB.

Ejigu GS, Woldeamanuel Y, Shah NS, Gebyehu M, Selassie A, Lemma E.

Int J Tuberc Lung Dis. 2008 Mar;12(3):332-7.

PMID:
18284841
15.

Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay.

Fitzwater SP, Sechler GA, Jave O, Coronel J, Mendoza A, Gilman RH, Friedland JS, Moore DA.

Eur Respir J. 2013 May;41(5):1163-71. doi: 10.1183/09031936.00059812. Epub 2012 Aug 16.

16.

[Multicenter evaluation of the indirect nitrate reductase assay for the rapid detection of multidrug-resistant tuberculosis].

Çoban AY, Taştekin B, Uzun M, Kalaycı F, Ceyhan İ, Biçmen C, Albay A, Sığ AK, Özkütük N, Sürücüoğlu S, Özkütük A, Esen N, Albayrak N, Aslantürk A, Sarıbaş Z, Alp A.

Mikrobiyol Bul. 2016 Jan;50(1):140-6. Turkish.

17.

Drug susceptibility test of Mycobacterium tuberculosis by nitrate reductase assay.

Ani AE, Daylop YB, Agbaji O, Idoko J.

J Infect Dev Ctries. 2009 Feb 28;3(1):16-9.

18.
19.

Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis.

Lazarus RP, Kalaiselvan S, John KR, Michael JS.

Indian J Med Microbiol. 2012 Jan-Mar;30(1):64-8. doi: 10.4103/0255-0857.93039.

20.

Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.

Yuen CM, Kurbatova EV, Tupasi T, Caoili JC, Van Der Walt M, Kvasnovsky C, Yagui M, Bayona J, Contreras C, Leimane V, Ershova J, Via LE, Kim H, Akksilp S, Kazennyy BY, Volchenkov GV, Jou R, Kliiman K, Demikhova OV, Vasilyeva IA, Dalton T, Cegielski JP.

PLoS Med. 2015 Dec 29;12(12):e1001932. doi: 10.1371/journal.pmed.1001932. eCollection 2015 Dec.

Supplemental Content

Support Center